Investigation of Combined Treatment of Acupuncture and Neurofeedback for Improving Cognitive Function in Mild Neurocognitive Disorder: a randomized, assessor-blind, pilot study

Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 44 人开始时间: 待定最近更新: 2022年4月4日

试验速览

暂无简介。

•1) Mild Neurocognitive Disorder patients who meet Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) criteria
•2) Korean version of Montreal Cognitive Assessment (MoCA-K) scores less than 22
•3) Education level of more than 6 years
•4) Participants who understood the purpose of this study and voluntarily signed the informed consent form

•1) Alzheimer, vascular dementia, Parkinson's disease, huntington's disease, hydrocephalus
•2) Presenting mental disorder including schizophrenia, delusional disorder, major depressive disorder, bipolar disorder, alcohol dependence, substance-related disorders, and etc. based on DSM-5
•3) Presence or history of neurological disorders, including epilepsy, regional brain damage, head injury, stroke, and etc.
•4) Receiving treatments or participating other clinical study within the last 4 weeks due to Mild Neurocognitive Disorder
•5) Having test for Mild Neurocognitive Disorder within the last 12 weeks
•6) Pregnant or lactating women
•7) Unstable medical state (assessment by research doctor with vital signs, laboratory test, ECG test)
•8) Hypertension, blood pressure excessing 160mmHg systolic and 95mmHg diastolic
•9) Significant liver disease or excessing serum AST, ALT, ?-GTP levels than twice over references
•10) Unavailable to measure f-NIRS
•11) Disagreement with acupuncture treatment
•12) Participant, who is probably uncooperative in the study or judged by researcher as difficult to finish the study

发起方

Daejeon Korean Medicine Hospital of Daejeon University